alexa Novel Ab-interno Minimally Invasive Glaucoma Surgery (MIGS)-The XEN45 Microfistula
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

4th International Conference on Clinical & Experimental Ophthalmology
July 14-16, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Nir Shoham-Hazon and Vanessa Vera-Machado-Horvath
ScientificTracks Abstracts: J Clin Exp Ophthalmol
DOI: 10.4172/2155-9570.S1.017
Abstract
Purpose: The aim of this study is to evaluate the effectiveness of the novel ab-interno MIGS fistula-XEN45 in reducing intraocular pressure (IOP) and glaucoma medication in patients with Open-Angle Glaucoma (OAG). Patients and Methods: This is a multicenter, open-labeled prospective study, in which 76 patients with OAG were enrolled. Effectiveness was assessed by comparing baseline intraocular pressure values to postoperative values. Success criteria were classified according to the Tube vs Trab study.All patients underwent the ab-interno XEN45 procedure. The surgery was performed as a primary procedure, or in combination with cataract surgery. Result: Mean IOP ranged from 22.44.7 preoperatively, to 13.18.0 postoperatively. Mean IOP lowering was 10.0 mmHg at 9 months of follow-up, a drop of 38%. Preoperative medication classes were 3.2, which shown a statistically significant decline to 0.4 postoperatively. Eighty eight percent (88%) of patients reached an IOP of 18mmHg or 20% drop, and 63% of patients reached an IOP of 16 or 30% drop. Conclusion: The novel XEN45 MIGS implant, has proven to be effective for Glaucoma in a MIGS approach. Intraocular pressure dropped by more than 30%, and was 18, in almost 90% of the patients who were evaluated at last follow-up. The XEN45 showed a statistically significant decline in the amount of glaucoma medication classes used, from 3.2 to 0.4. The goal of this study is to investigate a larger number of patients over a longer follow-up period (up to 3 years).
Biography
Shoham-Hazon has completed an Ophthalmology residency in Israel, in January 2010. During his residency he was appointed chief resident and was awarded two resident awards of excellence. Thereafter, Shoham-Hazon pursued the lucrative fellowship at the University of Toronto, with the world renowned, Ike Ahmed. This three year fellowship included clinical, surgical and research aspects of Glaucoma, Advanced Anterior Segment & IOL surgery (GAASS). During this fellowship, Shoham-Hazon received numerous awards for presentations in international conferences and research grants for research studies. Shoham-Hazon is a reviewer and guest reviewer for various international peer-review journals
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords